Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat

Psychopharmacology

Volumn 154, Issue 1, 2001, Pages 50-60

  Castanon, N ^a   Bluthe R M ^a   Dantzer, R ^a  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

Central versus periphery; IL 1 ; LPS; Rat; Sickness behavior; Tianeptine

Indexed keywords

ANTIDEPRESSANT AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TIANEPTINE;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR MODIFICATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FOOD INTAKE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; ILLNESS BEHAVIOR; IMMUNE RESPONSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; ENDOTOXINS; EXPLORATORY BEHAVIOR; IMMUNE SYSTEM; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SOCIAL BEHAVIOR; THIAZEPINES; WEIGHT LOSS;

EID: 0035118649     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000595     Document Type: Article

References (56)

1. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta
2. Effect of tricyclic antidepressant drugs on lymphocyte membrane structure
3. Regulation of corticosteroid receptor gene expression in depression and antidepressant action
4. Immune-neuroendocrine interactions: Facts and hypotheses
5. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat
6. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats
7. 2 receptors and the abundance of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat
8. Prediction of the depressive effects of interferon alfa by the patient's initial affective state
9. More on the depressive effects of interferon alfa
10. Depression, stress and immunological activation: The role of cytokines in depressive disorders
11. Olfactory bulbectomy provokes a suppression of interleukin-1β and tumor necrosis factor-α production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment
12. Molecular basis of sickness behavior
13. Cytokines and depression: Fortuitous or causative association?
14. Cytokine effects on behavior
15. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis
16. Immunological effects of neuropsychotropic substances
17. Effects of cytokines on cerebral neurotransmission
18. Tianeptine stimulates uptake of 5-hydroxytrytamine in vivo in the rat brain
19. IL-10 inhibits cytokine production by activated macrophages
20. Amitryptyline attenuates the febrile response to a pyrogen in rabbits
21. Tianeptine treatment induces regionally specific changes in monoamines
22. Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1β in mice
23. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
24. Reduction of immune function in life stress and depression
25. The olfactory bulbectomized rat as a model of depression
26. Neurochemical profile of tianeptine, a new antidepressant drug
27. The effect of tianeptine and sertraline in three animal models of depression
28. Sickness behavior as a new target for drug development
29. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression
30. Effect of desipramine on immunological parameters in mice, and their reversal by stress
31. Relationship of body energy status to inflammation-induced anorexia and weight loss
32. The in vitro immunosuppressive effects of moclobemide in healthy volunteers
33. Inflammation and brain function under basal conditions and during long-term elevation of brain corticotropin-releasing hormone levels
34. Position of tianeptine among antidepressive chemotherapies
35. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine
36. The monocyte-T-lymphocyte hypothesis of major depression
37. Negative immunoregulatory effects of antidepressants: Inhibition of interferon-γ and stimulation of interleukin-10 secretion
38. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock
39. Interferon as mediators of psychiatric morbidity
40. Antidepressants in long-term treatment
41. Is there evidence for an effect of antidepressant drugs on immune function?
42. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls
43. Effect of prolonged administration of tianeptine on 5-HT neurotransmission: An electrophysiological study in the rat hippocampus and dorsal raphe
44. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat
45. The macrophage theory of depression
46. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
47. The effects of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function
48. Induction of interleukin-1β and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain
49. Animal behavioural studies in the evaluation of antidepressant drugs
50. Analgesic effect of tianeptine in mice
51. Cytokine production in major depressed patients before and after clomipramine treatment
52. Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour
53. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression
54. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells
55. Endotoxin produces a depressive-like episode in rats
56. Cytokines, "depression due to a general medical condition", and antidepressant drugs